Extension of the SAEM algorithm to left-censored data in nonlinear mixed-effects model: Application to HIV dynamics model
暂无分享,去创建一个
[1] L B Sheiner,et al. Estimating population kinetics. , 1982, Critical reviews in biomedical engineering.
[2] J. Hughes,et al. Mixed Effects Models with Censored Data with Application to HIV RNA Levels , 1999, Biometrics.
[3] V De Gruttola,et al. Estimation of HIV dynamic parameters. , 1998, Statistics in medicine.
[4] D. Rubin,et al. Maximum likelihood from incomplete data via the EM - algorithm plus discussions on the paper , 1977 .
[5] Alan S. Perelson,et al. Decay characteristics of HIV-1-infected compartments during combination therapy , 1997, Nature.
[6] A. Ding,et al. Assessing antiviral potency of anti-HIV therapies in vivo by comparing viral decay rates in viral dynamic models. , 2001, Biostatistics.
[7] Lang Wu,et al. A Joint Model for Nonlinear Mixed-Effects Models With Censoring and Covariates Measured With Error, With Application to AIDS Studies , 2002 .
[8] C. Robert. Simulation of truncated normal variables , 2009, 0907.4010.
[9] E. Kuhn,et al. Coupling a stochastic approximation version of EM with an MCMC procedure , 2004 .
[10] Stuart L. Beal,et al. Ways to Fit a PK Model with Some Data Below the Quantification Limit , 2001, Journal of Pharmacokinetics and Pharmacodynamics.
[11] É. Moulines,et al. Convergence of a stochastic approximation version of the EM algorithm , 1999 .
[12] D Commenges,et al. Analysis of left-censored longitudinal data with application to viral load in HIV infection. , 2000, Biostatistics.
[13] Adrian F. M. Smith,et al. Sampling-Based Approaches to Calculating Marginal Densities , 1990 .
[14] D. Rubin,et al. Parameter expansion to accelerate EM: The PX-EM algorithm , 1998 .
[15] Russell D. Wolfinger,et al. Laplace's approximation for nonlinear mixed models. , 1993 .
[16] Lang Wu. Exact and Approximate Inferences for Nonlinear Mixed-Effects Models With Missing Covariates , 2004 .
[17] Philippe Flandre,et al. Nevirapine or lamivudine plus stavudine and indinavir: examples of 2-class versus 3-class regimens for the treatment of human immunodeficiency virus type 1. , 2002, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[18] Mats O. Karlsson,et al. Impact of Omission or Replacement of Data Below the Limit of Quantification on Parameter Estimates in a Two-Compartment Model , 2002, Pharmaceutical Research.
[19] France Mentré,et al. The SAEM algorithm for group comparison tests in longitudinal data analysis based on non‐linear mixed‐effects model , 2007, Statistics in medicine.
[20] A A Ding,et al. Relationships between antiviral treatment effects and biphasic viral decay rates in modeling HIV dynamics. , 1999, Mathematical biosciences.
[21] T. Louis. Finding the Observed Information Matrix When Using the EM Algorithm , 1982 .
[22] Hulin Wu,et al. A Comparison Study of Models and Fitting Procedures for Biphasic Viral Dynamics in HIV‐1 Infected Patients Treated with Antiviral Therapies , 2000, Biometrics.
[23] Hulin Wu,et al. The study of long‐term HIV dynamics using semi‐parametric non‐linear mixed‐effects models , 2002, Statistics in medicine.
[24] D. Bates,et al. Nonlinear mixed effects models for repeated measures data. , 1990, Biometrics.
[25] Hulin Wu,et al. Identification of significant host factors for HIV dynamics modelled by non‐linear mixed‐effects models , 2002, Statistics in medicine.
[26] L Wu,et al. A multiple imputation method for missing covariates in non‐linear mixed‐effects models with application to HIV dynamics , 2001, Statistics in medicine.
[27] Marc Lavielle,et al. Maximum likelihood estimation in nonlinear mixed effects models , 2005, Comput. Stat. Data Anal..